Advertisement
Research Article| Volume 203, ISSUE 1, P304-310, March 2009

Smoking, smoking cessation and inflammatory markers in older Chinese men: The Guangzhou Biobank Cohort Study

      Abstract

      Aims

      Smoking increases the risk of cardiovascular disease and inflammation plays a key role in the process of atherosclerosis. We therefore study the role of smoking and smoking cessation on the levels of inflammatory markers, C-reactive protein (CRP) and white blood cell (WBC) count, in older Chinese men.

      Methods

      This cross-sectional analysis included 2999 men aged 50–85 years who received a medical check-up including measurement of fasting plasma vascular risk factors. Information on smoking status, socioeconomic and lifestyle factors was collected by standardized interview.

      Results

      After adjustment for potential confounders, both CRP and WBC increased linearly across never, former and current smokers (both p < 0.01). The odds ratios of elevated CRP and WBC (upper tertiles) were also increased across never, former and current smokers (both p < 0.01). Dose–response relationships were observed among current smokers. Compared to current smokers, the odds ratios of elevated CRP and WBC and means of CRP and WBC declined with longer duration of smoking cessation (all p < 0.01).

      Conclusions

      Smoking is associated with increased CRP and WBC levels, and smoking cessation is associated with the reduction of the increase, confirming the benefits of quitting. Inflammation may be a potential mechanism by which smoking promotes atherosclerotic disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Prescott E.
        • Hippe M.
        • Schnohr P.
        • Hein H.O.
        • Vestbo J.
        Smoking and risk of myocardial infarction in women and men: longitudinal population study.
        BMJ. 1998; 316: 1043-1047
        • Shinton R.
        • Beevers G.
        Meta-analysis of relation between cigarette smoking and stroke.
        BMJ. 1989; 298: 789-794
        • Feigin V.
        • Parag V.
        • Lawes C.M.
        • et al.
        Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: an overview of 26 cohorts involving 306,620 participants.
        Stroke. 2005; 36: 1360-1365
        • Wannamethee S.G.
        • Shaper A.G.
        • Whincup P.H.
        • Walker M.
        Smoking cessation and the risk of stroke in middle-aged men.
        JAMA. 1995; 274: 155-160
        • Ockene I.S.
        • Miller N.H.
        Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction.
        Circulation. 1997; 96: 3243-3247
        • Dobson A.J.
        • Alexander H.M.
        • Heller R.F.
        • Lloyd D.M.
        How soon after quitting smoking does risk of heart attack decline?.
        J Clin Epidemiol. 1991; 44: 1247-1253
        • Ambrose J.A.
        • Barua R.S.
        The pathophysiology of cigarette smoking and cardiovascular disease: an update.
        J Am Coll Cardiol. 2004; 43: 1731-1737
        • Ross R.
        Atherosclerosis—an inflammatory disease.
        N Engl J Med. 1999; 340: 115-126
        • Elkind M.S.
        Inflammation, atherosclerosis, and stroke.
        Neurologist. 2006; 12: 140-148
        • Hansson G.K.
        • Robertson A.K.
        • Soderberg-Naucler C.
        Inflammation and atherosclerosis.
        Annu Rev Pathol. 2006; 1: 297-329
        • Ridker P.M.
        C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
        J Am Coll Cardiol. 2007; 49: 2129-2138
        • Imano H.
        • Sato S.
        • Kitamura A.
        • et al.
        Leukocyte count is an independent predictor for risk of acute myocardial infarction in middle-aged Japanese men.
        Atherosclerosis. 2007; 195: 147-152
        • Bazzano L.A.
        • He J.
        • Muntner P.
        • Vupputuri S.
        • Whelton P.K.
        Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.
        Ann Intern Med. 2003; 138: 891-897
        • Wannamethee S.G.
        • Lowe G.D.
        • Shaper A.G.
        • Rumley A.
        • Lennon L.
        • Whincup P.H.
        Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
        Eur Heart J. 2005; 26: 1765-1773
        • Frohlich M.
        • Sund M.
        • Lowel H.
        • Imhof A.
        • Hoffmeister A.
        • Koenig W.
        Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).
        Eur Heart J. 2003; 24: 1365-1372
        • Smith M.R.
        • Kinmonth A.L.
        • Luben R.N.
        • et al.
        Smoking status and differential white cell count in men and women in the EPIC-Norfolk population.
        Atherosclerosis. 2003; 169: 331-337
        • Tracy R.P.
        • Psaty B.M.
        • Macy E.
        • et al.
        Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.
        Arterioscler Thromb Vasc Biol. 1997; 17: 2167-2176
        • Bermudez E.A.
        • Rifai N.
        • Buring J.E.
        • Manson J.E.
        • Ridker P.M.
        Relation between markers of systemic vascular inflammation and smoking in women.
        Am J Cardiol. 2002; 89: 1117-1119
        • Ohsawa M.
        • Okayama A.
        • Nakamura M.
        • et al.
        CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers.
        Prev Med. 2005; 41: 651-656
        • Crook M.A.
        • Scott D.A.
        • Stapleton J.A.
        • Palmer R.M.
        • Wilson R.F.
        • Sutherland G.
        Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation.
        Eur J Clin Invest. 2000; 30: 861-865
        • Jiang C.
        • Thomas G.N.
        • Lam T.H.
        • et al.
        Cohort profile: the Guangzhou Biobank Cohort Study, a Guangzhou–Hong Kong–Birmingham collaboration.
        Int J Epidemiol. 2006; 35: 844-852
        • Lao X.Q.
        • Thomas G.N.
        • Jiang C.Q.
        • et al.
        C-reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study.
        Atherosclerosis. 2007; 194: 483-489
      1. International Physical Activity Questionnaire. http://www.ipaq.ki.se/ [last accessed December 15, 2005].

        • Ridker P.M.
        • Buring J.E.
        • Cook N.R.
        • Rifai N.
        C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
        Circulation. 2003; 107: 391-397
        • Sung K.C.
        Seasonal variation of C-reactive protein in apparently healthy Koreans.
        Int J Cardiol. 2006; 107: 338-342
        • Koh K.K.
        • Han S.H.
        • Quon M.J.
        Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
        J Am Coll Cardiol. 2005; 46: 1978-1985
        • Mayhan W.G.
        • Sharpe G.M.
        Effect of cigarette smoke extract on arteriolar dilatation in vivo.
        J Appl Physiol. 1996; 81: 1996-2003
        • Mayhan W.G.
        • Patel K.P.
        Effect of nicotine on endothelium-dependent arteriolar dilatation in vivo.
        Am J Physiol. 1997; 272: H2337-H2342
        • Ota Y.
        • Kugiyama K.
        • Sugiyama S.
        • et al.
        Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract—role of free radicals and attenuation by captopril.
        Atherosclerosis. 1997; 131: 195-202
        • Napoli C.
        • Ignarro L.J.
        Nitric oxide and atherosclerosis.
        Nitric Oxide. 2001; 5: 88-97
        • Lam T.H.
        • He Y.
        • Shi Q.L.
        • et al.
        Smoking, quitting, and mortality in a Chinese cohort of retired men.
        Ann Epidemiol. 2002; 12: 316-320